Article
Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern.
Molecular biology reports - 1 Jul 2020
Sanchez Paulina, Espinosa Magali, Maldonado Vilma, Barquera Rodrigo, Belem-Gabiño Nayeli, Torres Javier, Cravioto Adrian, Melendez-Zajgla Jorge
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in humans, with less than 5% 5-year survival rate. PDAC is characterized by a small number of recurrent mutations, including KRAS, CDKN2A, TP53, and SMAD4 and a long "tail" of infrequent mutated genes. Most of the studies have been performed in US and European populations, so new studies are needed to describe the mutational landscape of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
